EP1150746 - THE USE OF 4-H-1-BENZOPRYAN-4-ONE DERIVATIVES AS INHIBITORS OF SMOOTH MUSCLE CELL PROLIFERATION [Right-click to bookmark this link] | Status | No opposition filed within time limit Status updated on 15.07.2005 Database last updated on 17.07.2024 | Most recent event Tooltip | 17.06.2016 | Change - lapse in a contracting state | published on 20.07.2016 [2016/29] | Applicant(s) | For all designated states Aventis Pharmaceuticals Inc. Route 202-206, P.O. Box 6800 Bridgewater, NJ 08807-0800 / US | For all designated states THE BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM 201 West 7th Street Austin, Texas 78701 / US | [N/P] |
Former [2004/37] | For all designated states Aventis Pharmaceuticals Inc. Route 202-206, P.O. Box 6800 Bridgewater, NJ 08807-0800 / US | ||
For all designated states BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM 201 West 7th Street Austin, Texas 78701 / US | |||
Former [2001/45] | For all designated states Aventis Pharmaceuticals Inc. Route 202-206, P.O. Box 6800 Bridgewater, NJ 08807-0800 / US | ||
For all designated states BOARD OF REGENTS THE UNIVERSITY OF TEXAS SYSTEM 201 West 7th Street Austin, Texas 78701 / US | Inventor(s) | 01 /
PATTERSON, Winston, Campbell 1915 Avenue M Galveston, TX 77550 / US | 02 /
DUMONT, Jennifer, A. 37 Fawn Terrace Lane Groton, MA 01450 / US | [2001/45] | Representative(s) | Wein, Elmar Michael Sanofi-Aventis Deutschland GmbH Global Intellectual Property Department Industriepark Höchst Gebäude K 703 65926 Frankfurt am Main / DE | [N/P] |
Former [2001/45] | Wein, Elmar Michael, Dr. Aventis Pharma Deutschland GmbH, Patent- und Lizenzabteilung, K 801, Industriepark Höchst 65926 Frankfurt am Main / DE | Application number, filing date | 00909918.5 | 18.01.2000 | [2001/45] | WO2000US01104 | Priority number, date | US19990243380 | 01.02.1999 Original published format: US 243380 | US19990468665 | 21.12.1999 Original published format: US 468665 | [2001/45] | Filing language | EN | Procedural language | EN | Publication | Type: | A2 Application without search report | No.: | WO0044362 | Date: | 03.08.2000 | Language: | EN | [2000/31] | Type: | A2 Application without search report | No.: | EP1150746 | Date: | 07.11.2001 | Language: | EN | The application published by WIPO in one of the EPO official languages on 03.08.2000 takes the place of the publication of the European patent application. | [2001/45] | Type: | B1 Patent specification | No.: | EP1150746 | Date: | 08.09.2004 | Language: | EN | [2004/37] | Search report(s) | International search report - published on: | EP | 05.04.2001 | Classification | IPC: | A61P9/10, A61P9/00, A61K31/445 | [2001/45] | CPC: |
A61K31/453 (EP,US);
A61K31/436 (KR);
A61P21/00 (EP);
A61P35/00 (EP);
A61P43/00 (EP);
A61P9/00 (EP);
| Designated contracting states | AT, BE, CH, CY, DE, DK, ES, FI, FR, GB, GR, IE, IT, LI, LU, MC, NL, PT, SE [2004/37] |
Former [2001/45] | AT, BE, CH, CY, DE, DK, ES, FI, FR, GB, GR, IE, IT, LI, LU, MC, NL, PT, SE | Extension states | AL | 05.10.2001 | LT | 05.10.2001 | LV | 05.10.2001 | MK | 05.10.2001 | RO | 05.10.2001 | SI | 05.10.2001 | Title | German: | VERWENDUNG VON 4-H-1-BENZOPYRAN-4-ON-DERIVATEN ALS INHIBITOREN DER PROLIFERATION VON GLATTEN MUSKELZELLEN | [2004/10] | English: | THE USE OF 4-H-1-BENZOPRYAN-4-ONE DERIVATIVES AS INHIBITORS OF SMOOTH MUSCLE CELL PROLIFERATION | [2001/45] | French: | UTILISATION DE DERIVES DU 4-H-1-BENZOPYRAN-4-ONE COMME INHIBITEURS DE LA PROLIFERATION DES CELLULES DE MUSCLES LISSES | [2001/45] |
Former [2001/45] | VERWENDUNG VON 4-H-1-BENZOPYRAN-4-ON-DERIVATE ALS INHIBITOREN DER PROLIFERATION VON GLATTEN MUSKELZELLEN | Entry into regional phase | 03.09.2001 | National basic fee paid | 05.10.2001 | Designation fee(s) paid | 05.10.2001 | Examination fee paid | Examination procedure | 14.08.2000 | Request for preliminary examination filed International Preliminary Examining Authority: EP | 05.10.2001 | Examination requested [2001/48] | 09.09.2002 | Despatch of a communication from the examining division (Time limit: M04) | 25.02.2003 | Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time | 05.05.2003 | Reply to a communication from the examining division | 30.01.2004 | Communication of intention to grant the patent | 09.06.2004 | Fee for grant paid | 09.06.2004 | Fee for publishing/printing paid | Opposition(s) | 09.06.2005 | No opposition filed within time limit [2005/35] | Request for further processing for: | 05.05.2003 | Request for further processing filed | 06.05.2003 | Full payment received (date of receipt of payment) Request granted | 21.05.2003 | Decision despatched | Fees paid | Renewal fee | 31.01.2002 | Renewal fee patent year 03 | 20.01.2003 | Renewal fee patent year 04 | 02.02.2004 | Renewal fee patent year 05 |
Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Lapses during opposition Tooltip | MC | 31.01.2005 | [2016/29] |
Former [2010/20] | MC | 31.01.2005 | |
Former [2007/34] | IT | 18.01.2005 | |
MC | 31.01.2005 | ||
Former [2006/14] | MC | 31.01.2005 | Cited in | International search | [X]WO9716447 (MITOTIX INC [US], et al) [X] 1,5,6,9 * page 9, lines 1-8; claims 1-8,10,14-18,20,21,23-25,27,28,30 * * page 15, lines 34-37 * * page 28, lines 24-29 *; | [A]WO9742949 (BRISTOL MYERS SQUIBB CO [US]) [A] 1-3,5-9 * page 8, lines 23-27; claims 1-3; tables 1,2 *; | [XA]WO9813344 (BRISTOL MYERS SQUIBB CO [US]) [X] 1-3,5-7,9 * page 5, lines 25-30; claim 22 * [A] 8; | [A]WO9833798 (WARNER LAMBERT CO [US], et al) [A] 1-9 * page 1, lines 19-23; claims 25,35 ** page 3, lines 9-17 *; | [PX] - RUEF, JOHANNES ET AL, "Flavopiridol inhibits smooth muscle cell proliferation in vitro and neointimal formation in vivo after carotid injury in the rat", CIRCULATION (1999), 100(6), 659-665, XP000957367 [PX] 1-5,9 * the whole document * |